Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical ketorolac for diabetic macular edema
IRCT20180114038350N2Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ketorolac in diabetic macular edema (DME) (2 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoints: Change in macular edema and Change in visual activity. Started May 2018; status: completed.
02
Drugs
ketorolac
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on IRCT20180114038350N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180114038350N2.